Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
"The pharmaceutical company Merck said on Friday that in a final analysis of a clinical trial, its antiviral pill molnupiravir,reduced the risk of hospitalization and death among high-risk Covid patients by 30 percent, down from an earlier estimate of 50 percent. ....... Fluvoxamine, a common and inexpensive antidepressant, appears to be about as effective as molnupiravir. (bolding added)
"Pfizer’s antiviral pill, Paxlovid, which was found in a clinical trial to cut the risk of hospitalization and death by 89 percent, could become available within weeks." Let's see if, in the final analysis, this holds true!!!
Note of interest: "Monoclonal antibody drugs, which are typically administered intravenously in the United States, have been found to reduce hospitalizations and deaths by at least 70 percent."
